Variations of Steroid Hormone Metabolites in Serum and Urine in Polycystic Ovary Syndrome after Nafarelin Stimulation: Evidence for an Altered Corticoid Excretion. [PDF]
To evaluate the clinical relevance of testing pituitary-ovarian responses in patients suffering from polycystic ovary syndrome (PCOS) with the GnRH agonist nafarelin, a 1.2-mg dose of nafarelin was given intranasally to 19 women with PCOS and 15 healthy ...
Roger +18 more
core +1 more source
Objective: To compare clinical pregnancy rate through ICSI-ET between polycystic ovarian syndrome patients and women with normal ovaries (control group). We also investigated whether serum Anti-Müllerian hormone level or LH/FSH ratio may predict clinical
Tugba Elgun +3 more
doaj +1 more source
Introduction: Metabolic syndrome in polycystic ovarian syndrome is associated with a long-term risk of developing type 2 diabetes mellitus and cardiovascular disease.
Amrita Giri +3 more
doaj +3 more sources
Can Anti-Müllerian hormone predict the diagnosis of polycystic ovary syndrome? : A systematic review and meta-analysis of extracted data [PDF]
Context: Existing biochemical tests for polycystic ovary syndrome (PCOS) have poor sensitivity and specificity. Many women with PCOS have high anti-Müllerian hormone (AMH) concentrations; thus, this may be a useful addition to the diagnostic criteria ...
Iliodromiti, S. +7 more
core +1 more source
Objective: To determine the frequency of polycystic ovarian syndrome in female medical students and the risk factors associated with polycystic ovarian syndrome. Study Design: A cross-sectional analytical study.
Maria Ahmad +4 more
doaj +4 more sources
The Effect of a Video-Assisted Teaching Programme on Adolescent Girls' Awareness Regarding Early Detection of Polycystic Ovarian Syndrome [PDF]
Background: Polycystic ovarian syndrome is the most common endocrine disorder, affecting approximately 7-10% of women of reproductive age. Lack of awareness and poor lifestyle choices are considered to be the major factors leading to the syndrome.
Warda Talaat, Hanan Elsayed, Sahar Osman
doaj +1 more source
Genetics Poly Cystic Ovary Syndrome
Background: Polycystic ovarian syndrome is a complicated hereditary disorder which does not have specific reason and 6-10% of women at fertility age are involved.
Atekeh Bahadori +2 more
doaj +1 more source
Frequency of Metabolic Syndrome in Patients with Polycystic Ovarian Syndrome
Objective: To study the frequency of metabolic syndrome in patients with polycystic ovarian syndrome. Study Design: Cross-sectional study. Place and Duration of Study: The study was carried out at the outpatient Department of Gynecology Unit-II from 1st ...
Sadaf Imtiaz +5 more
doaj +1 more source
Effect of androgen treatment during foetal and/or neonatal life on ovarian function in prepubertal and adult rats [PDF]
We investigated the effects of different windows of testosterone propionate (TP) treatment during foetal and neonatal life in female rats to determine whether and when excess androgen exposure would cause disruption of adult reproductive function ...
Alan S McNeilly +17 more
core +1 more source
FREQUENCY OF GENERALIZED ANXIETY DISORDERS IN PATIENTS WITH POLYCYSTIC OVARIAN SYNDROME
Objective: To determine the factors associated with generalized anxiety disorders in patients presenting with polycystic ovarian syndrome. Study Design: Cross-sectional study.
Rabia Asghar +5 more
doaj +1 more source

